Hyperbilirubinemia: Does it matter?

Canadian Journal of Gastroenterology

Volumn 13, Issue 8, 1999, Pages 663-668

  Okolicsanyi, Lajos ^a   Cavestro, Giulia Martina ^b   Guatti Zuliani, Claudia ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b NONE

Author keywords

Bilirubin; Hyperbilirubinemia; Liver disease; Orthoptic liver transplantation

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; CRIGLER NAJJAR SYNDROME; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; GILBERT DISEASE; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LIVER DISEASE; LIVER METABOLISM; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

EID: 0033383648     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/648498     Document Type: Review

References (28)

1. Gilbert A, Lereboullet P. La cholemie simple familiale. Semaine Medicale 1901;31:241-3.
2. Okolicsanyi L, ed. Familial Hyperbilirubinemia. New York: Wiley & Sons, 1980.
3. Arnold J, Otto G, Kraus T, Kommerell B, Theilmann L. Gilbert's syndrome: a possible cause of hyperbilirubinemia after orthotopic liver transplantation. J Hepatol 1992;14:404.
4. Lachaux A, Aboufadel A, Chambon M, et al. Gilbert's syndrome: a possible cause of hyperbilirubinemia after orthotopic liver transplantation. Transplant Proc 1996;28:2846.
5. Jansen PLM, Bosma PJ, Bakker C, Lems SPM, Sloff MJH, Haagsma EB. Persistent unconjugated hyperbilirubinemia after liver transplantation due to an abnormal bilirubin UDP-glucuronosyltransferase gene promoter sequence in the donor. J Hepatol 1997;27:1-5.
6. Okolicsanyi L, Frei J, Magnenat P, Naccarato R. Multiplicity and specificity of UDP-glucuronyl transferase. Enzyme 1971;12:658-73.
7. Bosma PJ, Seppen J, Goldhoorn B, et al. Bilirubin UDP glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1993;268:235-9.
8. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-5.
9. Bosma PJ, Chowdhury NR, Goldhoorn BG, et al. Sequence of exons and the flanking regions of human bilirubin UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. Hepatology 1992;15:941-7.
10. van der Veere CN, Sinaasappel M, McDonagh AF, et al. Current therapy for Crigler-Najjar syndrome type I: report of a world registry. Hepatology 1996;24:311-5.
11. Gupta S, Gorla GR, Irani AN. Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies. J Hepatol 1999;30:162-70.
12. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422-6.
13. Bosma PJ, Goldhoorn B, Oude Elferink RP, Sinaasappel M, Oostra BA, Jansen PL. A mutation in bilirubin uridine 5′ diphosphate glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology 1993;105:216-220.
14. Black M, Billing BH. Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease and Gilbert's syndrome. N Engl J Med 1969;280:1266-71.
15. Felsher BF, Craig JR, Carpio N. Hepatic bilirubin glucuronidation in Gilbert's syndrome. J Lab Clin Med 1973;81:829-37.
16. Fevery J, Van Steenbergen W, Sieg A, Muraca M. Pathophysiology of the hyperbilirubinemias. In: Tavoloni N, Berk PD, eds. Hepatic Transport and Bile Secretion: Physiology and Pathophysiology. New York: Raven Press, Ltd, 1993:637-47.
17. Berk PD, Bloomer JR, Howe RB, Berlin NI. Constitutional hepatic disfunction (Gilbert's syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med 1970;83:296-305.
18. Okolicsanyi L, Ghidini O, Orlando R, et al. An evaluation of bilirubin kinetics with respect to the diagnosis of Gilbert's syndrome. Clin Sci Mol Med 1978:54:539-47.
19. Powell LW, Hemingway E, Billing BH, Sherlock S. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med 1967;23:1108-12.
20. Owens D, Sherlock S. Diagnosis of Gilbert's syndrome: Role of reduced caloric intake. Br Med J 1973;3:559-63.
21. Okolicsanyi L, Orlando R, Venuti M, et al. A modeling study of the effect of fasting on bilirubin kinetics in Gilbert's syndrome. Am J Physiol 1981;240:R266-71.
22. Kotal P, Vitek L, Fevery J. Fasting-related hyperbilirubinemia in rats: the effect of decreased intestinal motility. Gastroenterology 1996;111:217-23.
23. Paulusma C, Kool M, Bosma P, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
24. Wada M, Toh S, Taniguchi K, et al. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/ Dubin-Johnson syndrome. Hum Mol Gen 1998;7:203-7.
25. Okolicsanyi L, Nassuato G, Strazzabosco M. Familial hyperbilirubinemias: clinical aspects. In: Tavoloni N, Berk PD, eds. Hepatic Transport and Bile Secretion: Physiology and Pathophysiology. New York: Raven Press, Ltd, 1993:649-64.
26. Rotor AB, Manahan L, Florentin A. Familial non-hemolytic jaundice with direct van den Bergh reaction. Acta Med Philipp 1948;5:37-49.
27. Wolkoff AW. Chronic conjugated hyperbilirubinemia: Dubin-Johnson and Rotor's syndromes. In: Okolicsanyi L, ed. Familial Hyperbilirubinemia. Chichester: Wiley & Sons, 1980:221-34.
28. Okolicsanyi L, Fevery J, Billing B, et al. How should mild, isolated unconjugated hyperbilirubinemia be investigated? Semin Liver Dis 1983;3:36-41.